Heron Therapeutics, Inc.

HRTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000818033

SEC filings (opens in a new tab)

No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Heron Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of HRTX: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	172	2	170	0
Shares	152.7M	121.6K	156.5M	+3.93M (+2.6%)
Value	$192.4M	$153.3K	$203.2M	+$11.0M (+5.7%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Heron Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to HRTX in Q4 2025
Institution	Shares	Value	% of portfolio
Panagora Asset Management Inc	440,252	$572.3K	0.00%
Quadrature Capital Ltd	227,784	$296.1K	0.00%
Group One Trading, L.P.	145,167	$188.7K	0.01%
Glenmede Trust Co NA	82,189	$106.8K	0.00%
Redwood Family Wealth LLC	64,500	$83.8K	0.08%
State of Wyoming	58,624	$76.2K	0.01%
Atom Investors LP	48,178	$62.6K	0.00%
Abel Hall, LLC	46,176	$60.0K	0.01%
Brevan Howard Capital Management LP	35,036	$45.5K	0.00%
Concurrent Investment Advisors, LLC	31,923	$41.5K	0.00%
Parkway Wealth Management Group, LLC	25,000	$32.5K	0.00%
StoneX Group Inc.	18,809	$24.5K	0.00%
Capital Investment Counsel, Inc	18,325	$23.8K	0.00%
Pekin Hardy Strauss, Inc.	15,992	$20.8K	0.00%
Cresset Asset Management, LLC	13,390	$17.4K	0.00%
Aigen Investment Management, LP	12,717	$16.5K	0.00%
Two Sigma Securities, LLC	12,136	$15.8K	0.00%
Red Door Wealth Management, LLC	10,400	$13.5K	0.00%
CIBC World Markets Corp	10,165	$13.2K	0.00%
Harbour Investments, Inc.	1,000	$1.30K	0.00%
GAMMA Investing LLC	889	$1.16K	0.00%
Lodestone Wealth Management LLC	250	$325	0.00%
Northwestern Mutual Wealth Management Co	188	$244	0.00%
Pinnacle Wealth Planning Services, Inc.	178	$231	0.00%
Farther Finance Advisors, LLC	52	$68	0.00%

Sold out (25)

Institutions that held Heron Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of HRTX in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Baker Bros. Advisors LP	4,251,951	$5.36M
Marshall Wace, LLP	1,308,861	$1.65M
Caption Management, LLC	734,297	$925.2K
Wellington Management Group LLP	525,774	$662.5K
Walleye Capital LLC	99,335	$125.2K
Motiv8 Investments LLC	69,245	$87.2K
J. Goldman & Co LP	67,592	$85.2K
Prudential Financial Inc	34,465	$43.4K
Wealth Alliance	32,000	$40.3K
GWM Advisors LLC	28,187	$35.5K
Voleon Capital Management LP	26,940	$33.9K
Wealth Enhancement Advisory Services, LLC	25,577	$33.8K
PKS Advisory Services, LLC	20,000	$25.2K
Virtu Financial LLC	16,928	$21.0K
Bank of Montreal	15,495	$19.5K
R Squared Ltd	15,219	$19.2K
Envestnet Asset Management Inc	14,780	$18.6K
AE Wealth Management LLC	14,651	$18.5K
D.A. Davidson & Co.	13,500	$17.0K
Creative Planning	12,409	$15.6K
Principal Financial Group Inc	11,654	$14.7K
Gleason Group, Inc.	6,670	$8.40K
Future Financial Wealth Managment LLC	3,500	$4.41K
Financial Consulate, Inc	500	$630
CNB Bank	500	$630

Not filed for Q4 2025 yet (2)

Institutions that held Heron Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HRTX in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Glenmede Investment Management, LP	105,326	$132.7K
CIBC Bancorp USA Inc.	16,307	$20.5K